| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |